Martha Lawrence’s Post

AccendoWave - A Pain #Data Company On some level, Eli #Lilly’s partnership with computing giant #Nvidia feels inevitable. The first pharma to reach a $1 trillion valuation teaming up with a tech firm that has ridden the #AI wave to a record-setting $5 trillion valuation of its own—a Wall Street supergroup, a la Cream, Audioslave or boygenius. But Lilly leaders told Fierce Biotech that a baser instinct is driving the drug giant’s decision to invest big in Nvidia and AI: anxiety.

To view or add a comment, sign in

Explore content categories